← Clinical Evidence

SRC-e131c017d8a9 Riley RD 2024

Evidence source and scope

Riley RD, Archer L, Snell KIE, et al. Evaluation of clinical prediction models (part 2): how to undertake an external validation study. BMJ. 2024;384:e074820. DOI 10.1136/bmj-2023-074820

This note indexes a cited or audit-added source. It may be an original study, review, guideline, form or methods reference. Treat the specific design and the evidence below as authoritative; a source note is not automatically a primary study.

DOI: 10.1136/bmj-2023-074820

Bibliographic record from the original reports

Access labels embedded in these original reference strings are historical. Current access and exact checked components are stated separately below.

Riley RD, Archer L, Snell KIE, et al. Evaluation of clinical prediction models (part 2): how to undertake an external validation study. BMJ. 2024;384:e074820. DOI 10.1136/bmj-2023-074820

Conditions: COND-PD Parkinson’s disease

Scoped audit evidence

These are source- and component-level audit summaries as of 3 October 2026. Access and comparison scope can differ by report; none certifies every result or the underlying raw data.

Parkinson’s disease — gait

GaitP24-26conceptual discrimination/calibration/external fixedmodelversusrefit;balanceP18same;predictionhorizonandclinicalutilitydistinct. Source locator: s2Summarypoints;s3WhatDoWeMeanByExternalValidation;laterSteps3-4 Limit: Methodologicalguidance ratherthan PDempiricalevidence. DoesnotconstituteformallycompletedPROBASTassessment.

Limitations: Only scoped comparisons, not whole-paper certification.

Parkinson’s disease — balance

GaitP24-26conceptual discrimination/calibration/external fixedmodelversusrefit;balanceP18same;predictionhorizonandclinicalutilitydistinct. Source locator: s2Summarypoints;s3WhatDoWeMeanByExternalValidation;laterSteps3-4 Limit: Methodologicalguidance ratherthan PDempiricalevidence. DoesnotconstituteformallycompletedPROBASTassessment.

Limitations: Only scoped comparisons, not whole-paper certification.

Parkinson’s disease — balance1

GaitP24-26conceptual discrimination/calibration/external fixedmodelversusrefit;balanceP18same;predictionhorizonandclinicalutilitydistinct. Source locator: s2Summarypoints;s3WhatDoWeMeanByExternalValidation;laterSteps3-4 Limit: Methodologicalguidance ratherthan PDempiricalevidence. DoesnotconstituteformallycompletedPROBASTassessment.

Limitations: Only scoped comparisons, not whole-paper certification.

Reports citing this source

Update record

Updating the wiki · Evidence and status guide